With more than 5,000 new cases of brain tumors identified each year in France, the needs for innovative treatments are immense. Stereotaxic radiosurgery offers a non -invasive alternative. The arrival of ZAP-X in Paris marks a decisive step, by associating medical expertise and precision innovation.
Radiochurgery technology that pushes the limits of the possible
Intracranial radiosurgery makes it possible to deliver, with extreme precision, bundles of high -dose rays to treat tumors or deep lesions of the brain, without incision or general anesthesia. Made of outpatient, this technique is now used to treat certain benign tumors, brain metastases or pathologies from the base of the skull.
In Lariboisière, this approach gained power thanks to ZAP-X. Dr. François Nataf, neurosurgeon at AP-HP, explains: “The acquisition of ZAP-X as part of a public-private partnership AP-HP Hartmann is an important step. This device is expanding the security and the field of pathologies that can be taken care of by radiochuruse, especially those of the skull base “.
Concrete benefits for patients
Designed exclusively for the cranial box, the ZAP-X incorporates on-board guide technology, millimeter precision, and autonomous shielding not requiring bunker. Result: a secure, compact device, and more easily integrated in the hospital.
Patients benefit from treatment without hospitalization, painless, and a return home the same day. Ultimately, more than 700 patients per year should benefit from the Lariboisière hospital. This device is the second of this type installed in France, and the twentieth worldwide.
Professor Christophe Hennequin, head of the radiotherapy service at the Saint-Louis hospital, salutes this new dynamic: “An ambitious public-private project, carried out by a close collaboration between neurosurgeons and radiotherapists. A cutting edge technology, ultra precise and formidably effective, serving patients in radiosurgery. An expert, committed and ready to take up the challenge. All the ingredients are there to make the ZAP-X Lariboisière project a real success! “.
The care path with ZAP-X
For the patient, the treatment takes place in three main stages: an initial consultation with a neurosurgeon or a radiotherapist, followed by dedicated imaging (MRI or CT scan), then the radiosurgery session with the ZAP-X. The entire process is coordinated within the Lariboisière hospital, with a team specializing in stereotaxic radiochuruse. The majority of patients can go home the same day from treatment.
A vision of research and integrated care
This new equipment does not only represent a clinical advance. He also registers at the heart of research projects carried out jointly by the AP-HP, the ELSAN group and the scientific teams of Lariboisière.
Prof. Sébastien Froelich, head of the neurosurgery department, concludes: “Thanks to this new advanced radiochurgery equipment, the neurosurgery service will now have all the therapeutic methods for the treatment of deep and complex lesions of the brain and the base of the skull. It was our ambition: it is a major advance for the management of our patients“.
But beyond care, Lariboisière and the ELSAN group intend to enroll this innovation in a structured research strategy. Several clinical protocols are already in development to refine protocols, assess long -term results and explore new therapeutic indications.